Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Lion and Infogen establish gene identification collaboration

Sep. 23, 1998

Genetronics reports continued success with electroporation therapy of cancer

Sep. 22, 1998

SB-234551 characterized as potent, selective, nonpeptide ETA receptor antagonist

Sep. 18, 1998

Nexell submits data requested by FDA

Sep. 18, 1998

First group 1 mGluR antagonist with submicromolar potency described by Lilly

Sep. 17, 1998

Inflammatory/immunological disease collaboration initiated by BMS and Molecumetics

Sep. 15, 1998

Tularik/JT establish new collaboration to develop orphan nuclear receptor modulators

Sep. 10, 1998

New tool now available for studying neurotensin receptors

Sep. 9, 1998

Cortech to form new European company to develop PSI technology

Sep. 4, 1998

CAT demonstrates value of ProxiMol technology

Sep. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...